Inhibition of Chikungunya Virus nsP2 Protease by Pantinin-1

09 Apr 20264 min read0 viewsJournal Feed

GIST

by Mohammadamin Mastalipour, Mônika Aparecida Coronado, Jorge Enrique Hernández González, Dieter Willbold, Raphael Josef Eberle Climate change has facilitated the spread of arboviruses like the Chikungunya virus (CHIKV). CHIKV, a re-emerging virus from the Togaviridae family, has caused numerous global outbreaks.

The absence of antiviral therapy against CHIKV poses a significant threat to public health. The cleavage of the viral polyprotein relies on the catalytic activity of nsP2, crucial for viral replication.

Therefore the nsP2 protease presents a promising target for antiviral drug development. Animal venom-derived peptides demonstrated potential in combating various diseases including infections, cancer, and neurodegenerative disorders.

In this study, we assessed the inhibitory effects of pantinin-1, a peptide derived from the scorpion Pandinus imperator with broad antimicrobial activity, against CHIKV nsP2 protease. Pantinin-1 effectively inhibited CHIKV nsP2 protease, with a half-maximal inhibitory concentration (IC₅₀) of 6.4 ± 2.04 µM and complete inhibition at 175 µM.

Further examination revealed that pantinin-1 functions as a competitive inhibitor with low micromolar affinity and exhibited no toxicity up to 20 µM in cell culture.

Clinical Editorial

InhibitionTarget and Rationale

Focuses on CHIKV nsP2 protease, a pivotal enzyme for polyprotein processing and viral replication.
Highlights nsP2 protease as a plausible antiviral target in CHIKV.

Study Design and Methods

In vitro biochemical assessment of pantinin-1, a peptide from the scorpion Pandinus imperator, against CHIKV nsP2 protease.
Determined inhibitory parameters, including IC50 values, and evaluated functional inhibition characteristics.
Explored interaction mechanism via competitive inhibition assessment.
Supplemented by computational analyses: docking and molecular dynamics to characterize binding and identify implicated residues.

Population and Experimental Context

Experimental system centered on CHIKV nsP2 protease and pantinin-1; no in vivo or clinical population was involved.

Key Findings and Quantitative Signals

Pantinin-1 inhibited CHIKV nsP2 protease with an IC50 of 6.4 ± 2.04 µM.
Complete protease inhibition occurred at 175 µM.
Inhibition mechanism characterized as competitive, with low micromolar affinity.
Pantinin-1 showed no toxicity in cell culture up to 20 µM.
Computational work implicated specific residues in binding via docking and dynamics analyses.

Contextual Synthesis and Limitations

The study supports pantinin-1 as a potential lead compound targeting nsP2 protease for antiviral development against CHIKV.
No in vivo efficacy, pharmacokinetics, or clinical outcome data are reported.
Safety assessment is limited to cell culture; broader toxicity or off-target effects are not described.
Structural interaction insights are based on computational models paired with in vitro inhibition data.